Anti-MCM2 (phospho S53) antibody
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Polyclonal MCM2 phospho S53 antibody. Suitable for IHC-P, WB and reacts with Mouse, Human samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human MCM2 phospho S53.
View Alternative Names
BM28, CCNL1, CDCL1, KIAA0030, MCM2, DNA replication licensing factor MCM2, Minichromosome maintenance protein 2 homolog, Nuclear protein BM28
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MCM2 (phospho S53) antibody (AB70367)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma (left) and mouse renal cell carcinoma (right) tissues labelling MCM2 (phospho S53) with ab70367 at 1/200 (1µg/ml). Detection : DAB.
- WB
Unknown
Western blot - Anti-MCM2 (phospho S53) antibody (AB70367)
The bottom panel shows total MCM2 staining; the blot was stripped and then blotted with rabbit anti-total MCM2 antibody at 0.1 μg/ml. Detection : Chemiluminescence with exposure times of 3 minutes (upper panel) and 10 seconds (lower panel).
All lanes:
Western blot - Anti-MCM2 (phospho S53) antibody (ab70367) at 0.1 µg/mL
Lane 1:
Whole cell lysate from asynchronous 293T cells at 50 µg
Lane 2:
Whole cell lysate from asynchronous 293T cells treated with a phosphatase. at 50 µg
Predicted band size: 102 kDa
Observed band size: 117 kDa
false
- WB
CiteAb
Western blot - Anti-MCM2 (phospho S53) antibody (AB70367)
MCM2 (phospho S53) western blot using anti-MCM2 (phospho S53) antibody ab70367. Publication image and figure legend from Rodriguez-Acebes, S., Mourón, S., et al., 2018, J Biol Chem, PubMed 29959228.
ab70367 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab70367 please see the product overview.
The CDC7i test determines that low FR is the primary effect of PrimPol down-regulation.A, schematic of the simultaneous reduction in FR and IOD (higher origin density) caused by PrimPol down-regulation in HeLa cells (data shown in C–H). The CDC7i test can be applied. B, immunoblots showing the down-regulation of PrimPol and the effect of CDC7i on MCM2 phosphorylation at Ser-53. MEK2 levels are shown as a loading control. The first two lanes show serial 2-fold dilutions of the control condition (third lane) for comparison purposes. C–E, the result of applying the APH test. HeLa cells were treated with doxycycline for 4 days to induce shPrimPol, and 5 μm APH was added for 2 h when indicated. C, distribution of FR values (from left to right; n = 617, 615, 617, and 627). D, origin activity as determined by percentage of first-label origin structures (left panel; n = 1037, 1037, 1013, and 1044 total structures) and distribution of IOD values (right panel; n = 102, 107, 105, and 103). E, representative images of DNA fibers in HeLa cells treated as in C and D. Scale bar = 10 μm. F–H, HeLa cells were treated with doxycycline for 4 days to induce shPrimPol, and 60 μm CDC7i was added for 12 h when indicated. F, distribution of FR values (from left to right, n = 934, 979, 901, and 914). G, origin activity determined by percentage of first-label origin structures (left panel; n = 1514, 1588, 1641, and 1525 total structures) and distribution of IOD values (right panel; n = 141, 157, 37, and 39). H, representative images of DNA fibers in HeLa cells treated as indicated in F and G. Scale bar = 10 μm. In the dot plots, median values are indicated by horizontal lines. Bar graphs represent mean ± S.D. In C–E, data were pooled from two independent experiments. In F–H, data were pooled from three independent experiments.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MCM2 is part of the heterohexameric MCM complex including other proteins like MCM3 to MCM7. This complex serves as a helicase unwinding DNA to allow replication machinery access to the template strand. The activity of the MCM complex is tightly regulated to ensure that every section of genomic DNA is replicated once per cell cycle. Its proper function ensures genetic information replication accuracy and contributes to genome stability.
Pathways
MCM2 participates in essential biological processes such as the DNA replication pathway and the cell cycle regulatory pathway. The presence of MCM2 is critical for the G1/S transition phase of the cell cycle. It interacts with other proteins including CDC45 and GINS forming the active CMG helicase complex. This complex is pivotal in orchestrating the replication machinery and signaling pathway responses to ensure appropriate replication origin firing and accurate DNA synthesis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:5706 PubMed40593507
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 293:12855-12861 PubMed29959228
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 9:1590 PubMed29686321
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nature 467:343-6 PubMed20818375
2010
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com